Finance
Finance
Home4564 • TYO
OncoTherapy Science, Inc.
ÂĄ21.00
Jan 23, 6:15:03 PM GMT+9 · JPY · TYO · Disclaimer
StockJP listed security
Previous close
ÂĄ21.00
Day range
ÂĄ21.00 - ÂĄ22.00
Year range
ÂĄ19.00 - ÂĄ35.00
Market cap
7.91B JPY
Avg Volume
50.97M
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
(JPY)Sep 2025Y/Y change
Revenue
230.00M84.00%
Operating expense
101.00M6.32%
Net income
-241.00M0.82%
Net profit margin
-104.7846.10%
Earnings per share
——
EBITDA
——
Effective tax rate
-0.42%—
Total assets
Total liabilities
(JPY)Sep 2025Y/Y change
Cash and short-term investments
1.68B52.55%
Total assets
1.94B25.00%
Total liabilities
290.00M-47.18%
Total equity
1.64B—
Shares outstanding
338.64M—
Price to book
4.32—
Return on assets
-24.82%—
Return on capital
-31.55%—
Net change in cash
(JPY)Sep 2025Y/Y change
Net income
-241.00M0.82%
Cash from operations
——
Cash from investing
——
Cash from financing
——
Net change in cash
——
Free cash flow
——
About
Founded
Apr 6, 2001
Employees
47
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu